Cancer Biologics Market Growth Strengthened by Innovation and Increasing Healthcare Spending
The global cancer biologics market was valued at USD 94.5 billion in 2022 and is projected to witness steady growth, expanding at a CAGR of 7.7% from 2023 to 2031. Driven by the rising prevalence of cancer, increasing adoption of targeted therapies, and advancements in biotechnology, the market is expected to surpass USD 185.0 billion by the end of 2031. Growing investments in research and...
0 Commentaires 0 Parts 10 Vue 0 Aperçu